Skip to Main Content

Paper Details

A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a post hoc analysis of the RE-DUAL PCI trial.
EuroIntervention
5
2022
Author NameAffiliation
Deepak L BhattBrigham and Women's Hospital, Harvard Medical School
Christopher P CannonBrigham and Women's Hospital, Harvard Medical School
  • 1 - 2

Datasets

Release 1.2